Safety signals of perfluorohexyloctane ophthalmic solution in patients with dry eye disease
-
By
-
Zhengtai Sun
-
Yuting Liu
-
Lijuan Que
-
May 28, 2026
-
Clinical Scorecard: Evaluation of Safety Indicators for Perfluorohexyloctane Ophthalmic Solution in Individuals with Dry Eye Disease
At a Glance
| Category | Detail |
|---|
| Condition | |
| Key Mechanisms | Remove unsupported claims and ensure it is directly sourced. |
| Target Population | |
| Care Setting | |
Key Highlights
Guideline-Based Recommendations
Diagnosis
Management
- R
- e
- m
- o
- v
- e
-
- u
- n
- s
- u
- p
- p
- o
- r
- t
- e
- d
-
- r
- e
- c
- o
- m
- m
- e
- n
- d
- a
- t
- i
- o
- n
- s
- .
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Adults aged 18 and older with Dry Eye Disease.
Perfluorohexyloctane ophthalmic solution is a novel, preservative-free formulation with demonstrated short-term efficacy.
Clinical Best Practices
Related Resources & Content
